Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →12
🟢 Low
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,741
Total Claims
$611K
Drug Cost
1,085
Beneficiaries
$563
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+27%
Opioid rate vs peers
58.1% vs 45.9% avg
+17%
Cost per patient vs peers
$563 vs $483 avg
+38%
Brand preference vs peers
5.7% vs 4.1% avg
Opioid Prescribing
58.1%
Opioid Rate
3,916
Opioid Claims
$356K
Opioid Cost
15.1%
Long-Acting Rate
This provider's opioid prescribing rate of 58.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 385 claims · $313K
Generic: 6,356 claims · $297K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 87 | $75K |
| Oxycodone Hcl/Acetaminophen | 1,622 | $65K |
| Oxycodone Hcl | 76 | $57K |
| Lidocaine | 57 | $51K |
| Oxycodone Hcl/Acetaminophen | 11 | $40K |
| Methylnaltrexone Bromide | 13 | $32K |
| Rimegepant Sulfate | 16 | $31K |
| Oxycodone Hcl | 590 | $17K |
| Lactulose | 15 | $16K |
| Fentanyl | 98 | $15K |
| Pregabalin | 299 | $15K |
| Hydrocodone/Acetaminophen | 495 | $14K |
| Linaclotide | 24 | $13K |
| Naloxegol Oxalate | 31 | $13K |
| Lidocaine | 83 | $13K |
Prescribing Profile
38
Unique Drugs
12.0
Anomaly Score
Patient Profile
69
Avg Age
59%
Female
2.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About